This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Organoid: a promising solution to current challenges in cancer immunotherapy
npj Biomedical Innovations Open Access 12 December 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Related articles
Wagar, L. E. et al. Modeling human adaptive immune responses with tonsil organoids. Nat. Med. 27, 125–135 (2021)
Kastenschmidt, J. M. et al. Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids. Immunity 56, 1910–1926.e7 (2023)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.E.W. is a co-inventor on a US patent (US-20230235284-A1) describing the immune organoid technology.
Rights and permissions
About this article
Cite this article
Wagar, L.E. Human immune organoids: a tool to study vaccine responses. Nat Rev Immunol 23, 699 (2023). https://doi.org/10.1038/s41577-023-00956-9
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41577-023-00956-9
This article is cited by
-
Organoid: a promising solution to current challenges in cancer immunotherapy
npj Biomedical Innovations (2025)